Michael Shalmi

Michael Shalmi
Senior Partner

Michael has a broad knowledge of the health care business environment encompassing R&D as well as Marketing and Sales. Prior to joining Novo A/S he spent 15 years at Novo Nordisk where he held a number of international management positions with global responsibilities (V.P. International Marketing, Corporate VP Haemostasis and Chief Medical Officer BioPharm), European responsibility (V.P. of Haematology Business Unit, Zurich, Switzerland), and US responsibilities (V.P. BioPharm Business Unit (Princeton, USA). Most recently he served as Corporate V.P. Global Development, Clinical Operations Management at Novo Nordisk HQ. Michael is an MD, and holds an MBA.

Michael is a member of the board of directors of Orexo AB.